Sesen Bio (SESN) Competitors

Insmed (NASDAQ:INSM) and Sesen Bio (NASDAQ:SESN) are both mid-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, media sentiment, community ranking, earnings and institutional ownership.

Do analysts rate INSM or SESN?

Insmed presently has a consensus price target of $43.33, suggesting a potential upside of 125.23%.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Insmed	0 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	3.00
Sesen Bio	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Which has more risk & volatility, INSM or SESN?

Insmed has a beta of 1.53, suggesting that its share price is 53% more volatile than the S&P 500. Comparatively, Sesen Bio has a beta of 0.83, suggesting that its share price is 17% less volatile than the S&P 500.

Is INSM or SESN more profitable?

Sesen Bio has a net margin of 0.00% compared to Insmed's net margin of -212.33%. Sesen Bio's return on equity of 6.70% beat Insmed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Insmed	-212.33%	-3,789.32%	-41.78%
Sesen Bio	N/A	6.70%	5.41%

Does the media favor INSM or SESN?

In the previous week, Insmed had 4 more articles in the media than Sesen Bio. MarketBeat recorded 4 mentions for Insmed and 0 mentions for Sesen Bio. Insmed's average media sentiment score of 0.81 beat Sesen Bio's score of 0.00 indicating that Insmed is being referred to more favorably in the media.

Company	Overall Sentiment
Insmed	Positive
Sesen Bio	Neutral

Which has preferable earnings & valuation, INSM or SESN?

Sesen Bio has lower revenue, but higher earnings than Insmed. Insmed is trading at a lower price-to-earnings ratio than Sesen Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Insmed	$245.36 million	10.70	-$481.53 million	-$4.27	-4.51
Sesen Bio	$40 million	0.00	-$19.88 million	-$0.10	N/A

Do insiders & institutionals believe in INSM or SESN?

92.8% of Insmed shares are held by institutional investors. Comparatively, 16.5% of Sesen Bio shares are held by institutional investors. 4.3% of Insmed shares are held by insiders. Comparatively, 3.2% of Sesen Bio shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Does the MarketBeat Community prefer INSM or SESN?

Insmed received 343 more outperform votes than Sesen Bio when rated by MarketBeat users. Likewise, 65.15% of users gave Insmed an outperform vote while only 59.43% of users gave Sesen Bio an outperform vote.

Company	Underperform	Outperform
Insmed	Outperform Votes 488 65.15%	Underperform Votes 261 34.85%
Sesen Bio	Outperform Votes 145 59.43%	Underperform Votes 99 40.57%

Summary

Insmed beats Sesen Bio on 10 of the 15 factors compared between the two stocks.